Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide synthase (NOS)...
Keywords: dimethylarginine, endothelial dysfunction, inhibitor, NO pathway, risk factor
12/2004 | Clinical Chemical Laboratory Medicine, Walter de Gruyter